Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IL15-DC Vaccine in Patients With High Risk Melanoma - Exploratory Phase I/II Trial

NCT01189383 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT01189383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01189383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IL15-DC Vaccine in Patients With High Risk Melanoma - Exploratory Phase I/II Trial
Lead sponsor
Baylor Research Institute
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2011
Completion date
December 31, 2016
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma stage iii, malignant melanoma stage iv